GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genprex Inc (LTS:0A8I) » Definitions » General and Admin. Expense

Genprex (LTS:0A8I) General and Admin. Expense : $9.34 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Genprex General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Genprex's General and Admin. Expense for the three months ended in Mar. 2025 was $1.43 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 was $9.34 Mil.

Genprex General and Admin. Expense Historical Data

The historical data trend for Genprex's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genprex General and Admin. Expense Chart

Genprex Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.64 11.68 12.30 13.43 10.63

Genprex Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.72 4.85 1.57 1.50 1.43

Genprex General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genprex General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Genprex's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Genprex Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genprex Inc (LTS:0A8I) » Definitions » General and Admin. Expense
Comparable Companies
SNGX LYRA APM INDP LIPO ENZN ACUT APLM JAGX BCLI VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
GNPX:USA
Address
3300 Bee Cave Road, Suite 650-227, Austin, TX, USA, 78746
Website
https://www.genprex.com
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Genprex Headlines

No Headlines